A human rights approach to low data reporting in clinical trials of psychiatric deep brain stimulation

Research output: Contribution to journalArticlepeer-review

Abstract

The reporting of clinical trial data is necessary not only for doctors to determine treatment efficacy, but also to explore new questions without unnecessarily repeating trials, and to protect patients and the public from dangers when data are withheld. This issue is particularly salient in those trials involving invasive neurosurgical interventions, such as deep brain stimulation (DBS), for ‘treatment refractory’ psychiatric disorders. Using the federal database ClinicalTrials.gov, it was discovered that out of the completed or unknown-status trials related to psychiatric DBS up to November 2018, only two had submitted results to ClinicalTrials.gov. These results suggest that, despite federal requirements to report clinical trial data, reporting on psychiatric DBS trials is problematically minimal. It is argued that a human rights approach to this problem establishes a legal and ethical foundation for the need to report clinical trial results in this area.

Original languageEnglish (US)
Pages (from-to)1050-1058
Number of pages9
JournalBioethics
Volume33
Issue number9
DOIs
StatePublished - Nov 1 2019

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Philosophy
  • Health Policy

Fingerprint Dive into the research topics of 'A human rights approach to low data reporting in clinical trials of psychiatric deep brain stimulation'. Together they form a unique fingerprint.

Cite this